Skip to main content

Allopurinol

NDC 70771-1127 · Zydus Lifesciences Limited

Generic nameAllopurinol
Dosage formTABLET
RouteORAL
Active ingredient(s)ALLOPURINOL
Strength300 mg/1
Pharmacologic classXanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
Marketing categoryANDA

Packages

70771-1127-0 — 1000 TABLET in 1 BOTTLE (70771-1127-0)

70771-1127-1 — 100 TABLET in 1 BOTTLE (70771-1127-1)

70771-1127-5 — 500 TABLET in 1 BOTTLE (70771-1127-5)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70518-4062 — Allopurinol, 70518-4286 — allopurinol, 70518-4404 — ALLOPURINOL, 70518-4412 — allopurinol, 70518-4556 — Allopurinol, 70518-4693 — Allopurinol, 70710-1209 — Allopurinol, 70710-1210 — Allopurinol, 70710-2009 — Allopurinol, 70771-1126 — Allopurinol, 70771-1907 — Allopurinol, 71205-049 — ALLOPURINOL, 71205-208 — Allopurinol, 71205-377 — Allopurinol, 71335-0112 — ALLOPURINOL, 71335-0467 — allopurinol, 71335-1656 — allopurinol, 71335-2332 — Allopurinol, 71335-2347 — Allopurinol, 71335-2416 — Allopurinol, +142 more

Poisoning, adverse-effect and underdosing codes for this drug

The ICD-10-CM Table of Drugs and Chemicals carries these diagnosis codes for this drug — a drug-name match derived from FDA's product name and the Table of Drugs and Chemicals, not a CMS-published pairing.

T50.4X1 — Poisoning by drugs affecting uric acid metabolism, accidental (unintentional), T50.4X2 — Poisoning by drugs affecting uric acid metabolism, intentional self-harm, T50.4X3 — Poisoning by drugs affecting uric acid metabolism, assault, T50.4X4 — Poisoning by drugs affecting uric acid metabolism, undetermined, T50.4X5 — Adverse effect of drugs affecting uric acid metabolism, T50.4X6 — Underdosing of drugs affecting uric acid metabolism